How is your business helping to solve the health, social, or economic challenges created by COVID19?
Currently, clinical trials and clinical care for COVID-19 are limited to hospitals and traditional healthcare facilities. With an increase in infection and a shortage of healthcare professionals to tackle/manage this pandemic, it is essential to deliver high-quality patient-centered care within the comfort of one’s home. Patients with chronic conditions, complicated by COVID-19, face worse health outcomes, have higher hospital readmission rates. This means that such patients will require more complex, comprehensive, and regular care in order to maintain or improve their health. Telehealth and remote monitoring are exceptionally advantageous in the current situation considering the need to prevent overcrowding at healthcare facilities. Currently, a digital thermometer is often used as a sole predictor of infection or disease status with low sensitivity. But, COVID-19 detection and management need additional digital biomarkers that are currently undetected or under-utilized for which our device could be extremely valuable.The FDA recently issued guidance to help expand the availability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19. While the guidelines mention disparate device types such as ECG, cardiac monitor, Pulse Oximetry (SpO2), Non-invasive blood pressure (NIBP), and respiratory rate (RR), MouthLab integrates all these capabilities in a single, hand-held tool.
Does your business contribute most to recovery, response, or resilience?
Resilience - we're improving the broader infrastructure for responding to pandemic outbreaks.,Recovery - we're positioned to support in the recovery of those directly affected.,Response - we're responding directly to issues caused or exacerbated by the COVID-19 outbreak.
What is the stage of your product development?
I have a market-ready product/service. I could sell it to customers
What strengths does your team bring? Include skills and personal experience with the problem.
Currently, Aidar Health has 8 full-time members and four part-time members. Mr. Sathya Elumalai, the Co-founder and CEO of Aidar Health possesses over ten years of experience leading product development, program management, contract negotiation, and new business development. At Aidar, he is responsible for the overall product development initiatives, investor relationships, and securing key business partnerships. Mr. Elumalai previously served as the head of product at a leading healthcare data analytics firm. The genesis of our solution was due to the personal experience of Sathya, who was a care-giver to his mother with multiple chronic conditions. The idea was to create a simple solution in our device MouthLab that can easily assimilate into the life flow of individuals with chronic conditions.Dr. Gene Fridman, MS, Ph.D., is the Co-founder and CTO of Aidar Health. He is also an Assistant Professor in the Department of Biomedical Engineering at Johns Hopkins University. He has held consulting relationships with several biomedical engineering companies. He has built 5 medical devices in his 30+ years of biomedical engineering experience.The team is bolstered by the presence of accomplished professionals in the areas of nursing, engineering, business and strategy, quality and regulatory, and software development. The team is well complemented by its advisors, most notably, Dr. Bob Wise, Professor of Medicine, Pulmonary and Critical Care Medicine at JHMI, among others.
What countries do you operate in?
United States and India.
Is your company headquartered in a US "Opportunity Zone"?
Yes
